HIGHLIGHTS
- who: New York and colleagues from the Rockefeller University have published the Article: Autoantibodies against type I IFNs in patients with critical influenza pneumonia, in the Journal: (JOURNAL) of 05/02/2023
SUMMARY
The authors previously showed that auto-Abs against IFN-α2 neutralized the other 12 forms of IFN-α (Bastard et_al, 2020; Bastard et_al, 2021a). As in patients with critical COVID-19 and auto-Abs against type I IFNs (Bastard et_al, 2021a; Bastard et_al, 2020), the population of auto-Ab-positive patients with lifethreatening influenza was mostly male, although this was not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.